Efficacy and Safety of New and Emerging Drugs for COVID-19: Favipiravir and Dexamethasone

PURPOSE OF REVIEW: The widespread respiratory disease of virus known as severe acute respiratory syndrome–coronavirus 2019 (SAR-CoV-2) had infected more than 200 countries and caused pandemic and havoc in the world. RECENT FINDINGS: The genome of the virus was sequenced rapidly to study its mechanis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Curr Pharmacol Rep
Autors principals: Sood, Shivani, Bhatia, Gurpreet Kaur, Seth, Prachi, Kumar, Pawan, Kaur, Jagjit, Gupta, Vidisha, Punia, Sandeep, Tuli, Hardeep Singh
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2021
Matèries:
Clinical Pharmacology (L Brunetti, Section Editor)
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7889701/
https://ncbi.nlm.nih.gov/pubmed/33619447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40495-021-00253-w
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars